Abstract
Effective translation of research advances from the bench to clinical and public health practice at the bedside and in the community at large represents an important step in the health research discovery enterprise. Increasingly, the gap in translating these advances into practice is being recognized. Successfully addressing this translational gap for the prevention and control of chronic diseases will require the development of novel, innovative, and, if necessary, nontraditional approaches. Participants in the 8th International Conference on Vascular Endothelium discussed a variety of novel approaches that have significant promise. Three of these approaches-vaccine development, genomics and proteomics, and tissue engineering-are highlighted in this position statement and strategies for public health practice and research are suggested.
Original language | English |
---|---|
Pages (from-to) | 330 - 332 |
Number of pages | 3 |
Journal | Vascular Pharmacology |
Volume | 46 |
Issue number | 5 |
DOIs | |
Publication status | Published - May 2007 |
Keywords
- Animals
- Biomedical Research
- Cardiovascular Diseases
- Chronic Disease
- Diabetes Mellitus
- Diffusion of Innovation
- Endothelium, Vascular
- Genomics
- Humans
- Neoplasms
- Obesity
- Primary Prevention
- Proteomics
- Public Health Practice
- Tissue Engineering
- Vaccination